IT services and consulting firm Incedo is looking at ramping up its employee strength to 5,000 by adding 3,500 people in India and the US as it sees greater demand for data and analytics services across sectors.
"We are looking at getting a 5,000 headcount by 2018-end...And we are working on it. A substantial number will be in the US, about 1,000 either as full-time or contractors because we feel that working with customers requires agility and more engagement and thats the differentiator for us," he said," Incedo CEO Tejinderpal Singh Miglani told PTI.
Incedo is now looking at adding about 3,500 people to its teams in the US and India over the next two years, he said.
The Bay Area-headquartered firm has operations across North America, South Africa and India. Incedo was spun out as an independent entity from the technology unit of Indiabulls in 2011.
"Incedo is totally focussed on the digital space. We have been achieving growth of 60-70 per cent year-on-year for the last many years and this year too, we are on track to do about 70 per cent. So, obviously the headcount will grow with that," Miglani said.
While he declined to disclose revenue numbers, Miglani said about 80 per cent of the company's revenues come from the US and the remaining from India.
"We have achieved 6X growth in the last 4 years, in terms of revenue. About 60-70 per cent of the work we do is around data and analytics...India is about 1,200 people spread between Gurgaon, Bangalore and Chennai and the US is about 300 people," he said.
The enterprise data management market size is expected to grow from USD 64.7 billion in 2015 to over USD 105 billion by 2020. While North America is expected to remain as the biggest market, the Asia Pacific region is expected to experience increased market traction.
Miglani said the company started with working in multiple areas, including voice BPO but "very soon we realised that we want to stay focussed on our areas of speciality".
Incedo works with one of the top three global banks of the world and with some of the top 10 pharma/lifesciences companies globally.
Disclaimer: No Business Standard Journalist was involved in creation of this content
